SciSight Ecosystem
WoS SCIE Q3Scopus Q2SCImago #9,831CAS 4区Top JournalReview JournalHybrid

Current Vascular Pharmacology

Abbreviation (ISO):CURR. VASC. PHARMACOL
Country: England•WoS SCIE Quartile: Q3•Scopus SJR: 0.601•SCImago Rank: #9,831•Identifier (ISSN):1570-1611(Print)/1875-6212(Online)•Articles / Year: 54•Estimated Publication Fee (APC): $3,181 USD
Clarivate IF (2026)Q3
2.4
↑ +0.3

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (2021)
54

54 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate3.6%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
54articles/year
6.56% Gold OA•36.36% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

1.50pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q3(IF: 2.4)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20261.50đ
WoS Q3(IF: 2.4)
🔵 Computed
20251.50đ
WoS Q3(IF: 2.1)
🔵 Computed
20241.50đ
WoS Q3(IF: 2.8)
🔵 Computed
20231.50đ
WoS Q3(IF: 4.5)
🔵 Computed
20221.50đ
WoS Q3(IF: 3.524)
🔵 Computed
20211.50đ
WoS Q3(IF: 2.719)
🔵 Computed
20201.50đ
WoS Q3(IF: 2.672)
🔵 Computed
20191.50đ
WoS Q3(IF: 2.583)
🔵 Computed
20181.50đ
WoS Q3(IF: 2.087)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

Current Vascular Pharmacology publishes clinical and research-based reviews/mini-reviews, original research articles, letters, debates, drug clinical trial studies and guest edited issues to update all those concerned with the treatment of vascular disease, bridging the gap between clinical practice and ongoing research. Vascular disease is the commonest cause of death in Westernized countries and its incidence is on the increase in developing countries. It follows that considerable research is directed at establishing effective treatment for acute vascular events. Long-term treatment has also received considerable attention (e.g. for symptomatic relief). Furthermore, effective prevention, whether primary or secondary, is backed by the findings of several landmark trials. Vascular disease is a complex field with primary care physicians and nurse practitioners as well as several specialties involved. The latter include cardiology, vascular and cardio thoracic surgery, general medicine, radiology, clinical pharmacology and neurology (stroke units).

Topics Covered (Recognized by AI)
MedicineInternal medicine91.6%Biology90.9%Chemistry63.3%Endocrinology61%Biochemistry60.5%Pathology55.1%Cardiology49.5%Genetics44.9%Psychology44.9%Psychiatry40.2%Surgery36.5%Radiology28.6%Immunology26.1%Disease25.7%Intensive care medicine25.3%Diabetes mellitus24.8%Physics22.3%Pharmacology21.6%

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #9,831Scopus Q2SCImago Profile
Scopus Coverage:2003-2025
Scopus Broad Areas:MedicinePharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q2
0.601

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q2
Scopus H-Index (2025)
76

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
2.06

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,181 USD

Estimated Article Processing Charge for Open Access publication.

Chi phí ước tính / bài báo

Scopus 3-Year Publication & Citation Window

3-Year Citations273
3-Year Documents154
Citable Documents120

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate27.2%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Cardiology and Cardiovascular MedicineQ2
PharmacologyQ3

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
3区PHARMACOLOGY & PHARMACY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Hybrid
OA publishing option or traditional subscription
Publisher
Bentham Science Publishers B.V.
Publication Language
English
Frequency
Quarterly
Founding Year
2003
Editorial Address
BENTHAM SCIENCE PUBL LTD, EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, SHARJAH, U ARAB EMIRATES, 1200 BR
Indexing & Databases
SCIEScopusPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
PERIPHERAL VASCULAR DISEASE
JCRSCIE
53/100Q3
PHARMACOLOGY & PHARMACY
JCRSCIE
215/356Q3
PERIPHERAL VASCULAR DISEASE
JCISCIE
75/100Q3
PHARMACOLOGY & PHARMACY
JCISCIE
266/356Q3

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
YearImpact FactorArticles / YearTotal Citations
2026—281
20252.15297
20242.840173
20234.564307
20223.52444225
20212.71951588
20202.672801,380
20192.583642,722
20182.0871051,924
2017—1012,501
2016—982,042
2015—1082,050
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Current Vascular Pharmacology

WoS Q3
1346201820192020202120222023202420252.10
Annual Impact Factor Metric
2025:2.1

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 3.6%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 794cb520-86d2-492b-8f5b-03e5502b8f22
Database Updated: 2026-09-28